In oral poisoning with carbamate insecticides, which of the following may be hazardous?
Which of the following drugs is known to be hepatotoxic?
Drug monitoring is required for which of the following medications?
Therapeutic drug monitoring is indicated for which of the following medications?
The transmission of which of the following neurotransmitters is blocked in strychnine poisoning?
Which of the following is NOT a contraindication for BAL?
All of the following drugs are documented to be porphyrinogenic EXCEPT:
All of the following drugs can cause cholestatic jaundice EXCEPT:
Which of the following is NOT a function of an H1 antagonist?
Which of the following drugs is useful in the treatment of Malathion poisoning?
Explanation: **Explanation:** The core pharmacological difference between Organophosphate (OP) and Carbamate poisoning lies in the nature of the bond formed with the enzyme Acetylcholinesterase (AChE). **Why Pralidoxime is hazardous:** In carbamate poisoning (e.g., Carbaryl, Propoxur), the carbamylation of AChE is **spontaneously reversible** and occurs relatively quickly. Unlike OP compounds, carbamates do not undergo "aging." **Pralidoxime (2-PAM)**, a cholinesterase reactivator, is generally contraindicated or considered hazardous in carbamate poisoning because: 1. It has its own weak anticholinesterase activity, which can synergistically worsen the cholinergic crisis. 2. It may form a complex with carbamates that is more toxic than the carbamate itself (specifically seen with Carbaryl). 3. The enzyme recovery is already rapid; thus, the risks of oxime toxicity outweigh any potential benefits. **Analysis of Incorrect Options:** * **Atropine:** This is the **drug of choice** for both OP and carbamate poisoning. It antagonizes the muscarinic effects (SLUDGE symptoms) and is life-saving. * **Magnesium sulfate purgative:** Used in gastric decontamination to hasten the elimination of the unabsorbed poison from the GI tract. * **Gastric lavage with activated charcoal:** Standard emergency procedure for oral poisoning to reduce systemic absorption, provided the airway is protected. **NEET-PG High-Yield Pearls:** * **The Exception:** While oximes are generally avoided in carbamates, they are specifically contraindicated in **Carbaryl** poisoning. * **Aging:** OP compounds undergo "aging" (permanent bond), requiring oximes *before* aging occurs. Carbamates **do not age**. * **Management Tip:** If the type of insecticide (OP vs. Carbamate) is unknown, start Atropine immediately. Oximes are usually withheld unless OP poisoning is confirmed.
Explanation: ### Explanation **Correct Option: A (Chloroform)** Chloroform is a potent halogenated hydrocarbon that was historically used as an anesthetic but is now obsolete due to its severe **organotoxicity**. Its hepatotoxicity is primarily mediated by its metabolism in the liver via Cytochrome P450 enzymes into **phosgene**, a highly reactive and toxic metabolite. This leads to centrilobular hepatic necrosis and fatty degeneration of the liver. Additionally, chloroform is notoriously cardiotoxic, sensitizing the myocardium to catecholamines and potentially causing fatal arrhythmias. **Why Incorrect Options are Wrong:** * **B. Diethyl ether:** While ether is known for its irritating pungent odor and high inflammability/explosiveness, it is relatively safe for the liver. Its primary drawbacks are a slow induction/recovery period and a high incidence of post-operative nausea and vomiting (PONV). * **C. Nitrous oxide (N2O):** N2O is a non-toxic, non-irritating gas. It does not cause hepatotoxicity. Its main clinical concerns are megaloblastic anemia (due to oxidation of Vitamin B12) and diffusion hypoxia during recovery. **High-Yield NEET-PG Pearls:** * **Halothane:** The most famous anesthetic associated with "Halothane Hepatitis." Like chloroform, it is a halogenated agent; however, modern agents like **Sevoflurane** and **Desflurane** have negligible hepatic metabolism and are much safer. * **Methoxyflurane:** Highly **nephrotoxic** (due to inorganic fluoride release); it is the "sister" toxicity to Chloroform's hepatotoxicity. * **Carbon Tetrachloride (CCl4):** Though not an anesthetic, it is the classic pharmacological model for experimental hepatotoxicity via free radical formation.
Explanation: The correct answer is **Lithium**. This is because Lithium is a classic example of a drug with a **Narrow Therapeutic Index (NTI)**. For such drugs, the dose required for a therapeutic effect is very close to the dose that causes toxicity.Why Lithium is correct:Lithium requires mandatory **Therapeutic Drug Monitoring (TDM)** to ensure safety and efficacy. The therapeutic range for Lithium in acute mania is **0.8–1.2 mEq/L**, and for maintenance, it is **0.6–1.0 mEq/L**. Toxicity typically manifests when levels exceed 1.5 mEq/L. Monitoring is also essential because Lithium is excreted solely by the kidneys, and its clearance is affected by sodium levels and hydration status [1, 2].Why the other options are incorrect:* **Paracetamol:** It has a wide therapeutic window. Monitoring is only required in cases of acute overdose (using the Rumack-Matthew nomogram) to determine the need for N-acetylcysteine, not during routine therapy.* **Ampicillin:** Most antibiotics, including penicillins, have a high safety margin and do not require routine TDM. Dosing is standardized based on infection severity.* **Olanzapine:** While it requires monitoring for metabolic side effects (weight, blood sugar, lipids), it does not require plasma drug level monitoring as it has a broad therapeutic index.High-Yield NEET-PG Pearls:* **Mnemonic for NTI drugs (TDM required):** "**L**ist **W**ith **C**are **P**lease" — **L**ithium, **W**arfarin, **C**yclosporine/Digoxin, **P**henytoin/Theophylline.* **Lithium Sampling:** Blood for TDM should be drawn **12 hours after the last dose** (trough level) [1].* **Toxicity signs:** Coarse tremors, ataxia, vomiting, and diabetes insipidus.
Explanation: **Explanation:** **Therapeutic Drug Monitoring (TDM)** is the clinical practice of measuring drug concentrations in the blood to maintain a constant concentration within a specific **therapeutic window**. It is primarily indicated for drugs where the relationship between dose and plasma concentration is unpredictable, or where the margin between therapeutic and toxic doses is narrow. **Why Digoxin is Correct:** Digoxin has a **narrow therapeutic index** (typically 0.5–2.0 ng/mL). Small increases in plasma levels can lead to life-threatening toxicity, characterized by arrhythmias, gastrointestinal distress, and xanthopsia (yellow vision). Furthermore, its pharmacokinetics are influenced significantly by renal function and electrolyte imbalances (like hypokalemia), making TDM essential to ensure safety and efficacy. **Why Other Options are Incorrect:** * **A. Diuretics:** Effectiveness is monitored by clinical parameters such as urine output, weight reduction, and blood pressure, rather than plasma levels. * **B. Metformin:** Monitoring is based on therapeutic outcomes like HbA1c and blood glucose levels. There is no established correlation between plasma metformin levels and its clinical effect. * **C. Levodopa:** Clinical response (improvement in Parkinsonian symptoms) and the appearance of side effects (dyskinesia) are used to titrate the dose. **High-Yield NEET-PG Pearls:** * **Indications for TDM:** Remember the mnemonic **"THEAL"** – **T**ricyclic antidepressants, **H**eart medications (Digoxin, Amiodarone), **E**pilepsy drugs (Phenytoin, Carbamazepine), **A**minoglycosides (Gentamicin), and **L**ithium. * **Exceptions:** TDM is **not** required for drugs with a wide therapeutic index, drugs whose effect is easily measurable (e.g., BP for antihypertensives, INR for Warfarin), or "hit-and-run" drugs (e.g., Omeprazole). * **Digoxin Toxicity:** Hypokalemia increases the risk of Digoxin toxicity because both compete for the same binding site on the Na+/K+ ATPase pump.
Explanation: **Explanation:** **Strychnine** is a potent alkaloid derived from the seeds of *Strychnos nux-vomica*. Its primary mechanism of action is the **competitive antagonism of Glycine receptors**, specifically at the postsynaptic sites in the Renshaw cells of the spinal cord. * **Why Glycine is correct:** Glycine is the major inhibitory neurotransmitter in the spinal cord. By blocking glycine receptors, strychnine removes the normal inhibitory control over motor neurons. This leads to unchecked sensory stimulation, resulting in violent, involuntary muscle contractions and generalized seizures (opisthotonus). * **Why other options are incorrect:** * **GABA:** While GABA is the primary inhibitory neurotransmitter in the brain, its blockade is associated with drugs like **Picrotoxin** or **Bicuculline**, not strychnine. * **Glutamate:** This is the primary excitatory neurotransmitter. Blocking it would lead to CNS depression or anesthesia (e.g., Ketamine), the opposite of strychnine’s effect. * **Ach (Acetylcholine):** Strychnine does not significantly affect cholinergic transmission. Blockade of Ach at the neuromuscular junction (e.g., Curare) causes paralysis, not convulsions. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Presentation:** Patients present with "spinal seizures" characterized by **Opisthotonus** (archback), **Risus Sardonicus** (sardonic smile due to facial muscle spasms), and clear consciousness until death. * **Trigger:** Spasms are often triggered by minimal sensory stimuli (light, sound, or touch). * **Management:** The mainstay of treatment involves **Benzodiazepines** (to control spasms) and maintaining a quiet, dark environment to minimize triggers. * **Differentiation:** Unlike Tetanus (which inhibits glycine *release*), Strychnine *blocks the receptor* itself.
Explanation: **Explanation:** **BAL (British Anti-Lewisite / Dimercaprol)** is a chelating agent used for heavy metal poisoning. The correct answer is **Gold poisoning** because BAL is actually a **primary indication** for treatment, not a contraindication. **1. Why Gold Poisoning is the Correct Answer:** BAL contains sulfhydryl (-SH) groups that compete with endogenous enzymes for binding with heavy metals. It is specifically indicated for the treatment of toxicity resulting from **Gold, Arsenic, and Mercury**. Since it is used to treat gold-induced chrysotherapy side effects, it cannot be a contraindication. **2. Analysis of Contraindications (Incorrect Options):** * **Iron Poisoning:** BAL is strictly contraindicated here because it forms a **toxic complex** with iron that is highly nephrotoxic. The drug of choice for iron poisoning is Deferoxamine. * **Cadmium Poisoning:** Similar to iron, BAL forms a chelate with cadmium that redistributes to the kidneys, significantly increasing the risk of **renal failure**. * **G6PD Deficiency:** BAL can induce **intravascular hemolysis** in patients with G6PD deficiency due to its oxidizing potential. **Clinical Pearls for NEET-PG:** * **Route:** BAL must be administered via **deep Intramuscular (IM)** injection because it is dispensed in peanut oil (avoid in patients with peanut allergies). * **Urine pH:** It is most effective when the urine is **alkaline**, as this prevents the dissociation of the metal-chelator complex in the renal tubules. * **Lead Poisoning:** BAL is used in combination with EDTA for **Lead Encephalopathy** to prevent the redistribution of lead to the brain.
Explanation: **Explanation:**The primary mechanism behind drug-induced porphyria (specifically Acute Intermittent Porphyria) is the **induction of the enzyme ALA synthase**. This enzyme is the rate-limiting step in heme synthesis. When certain drugs stimulate the Cytochrome P450 (CYP450) system, they increase the demand for heme [1], which in turn relieves the negative feedback on ALA synthase, leading to the toxic accumulation of porphyrin precursors.**Why Aspirin is the Correct Answer:**Aspirin (Salicylates) is considered **non-porphyrinogenic** and is listed as a safe drug in patients with porphyria. It does not significantly induce the CYP450 system or ALA synthase, making it a safe analgesic choice for these patients. [2]**Why the other options are Porphyrinogenic:*** **Estrogen therapy:** Steroid hormones, including estrogens and oral contraceptives, are potent triggers for acute porphyric attacks. [1]* **Carbamazepine & Phenytoin:** Both are classic **enzyme inducers**. By inducing the hepatic CYP450 system, they rapidly deplete the regulatory heme pool, triggering a massive up-regulation of ALA synthase.**High-Yield Clinical Pearls for NEET-PG:*** **Common Porphyrinogenic Drugs (The "P"s):** **P**henobarbitone (and other Barbiturates), **P**henytoin, **P**yrazinamide, **P**rogesterone, and Griseofulvin.* **Safe Drugs in Porphyria:** Aspirin, Paracetamol, Morphine, Penicillin, and Atropine. [2]* **Clinical Presentation:** Patients typically present with the "5 Ps": **P**ainful abdomen, **P**olyneuropathy, **P**sychological disturbances, **P**ink urine, and **P**recipitated by drugs.* **Treatment of Choice:** Intravenous **Hematin** (Heme arginate) or Glucose loading, both of which inhibit ALA synthase via negative feedback.
Explanation: ### Explanation The key to answering this question lies in distinguishing between the two main types of drug-induced liver injury (DILI): **Cholestatic** (interference with bile flow) and **Hepatocellular** (direct damage to hepatocytes). **1. Why Isoniazid (INH) is the correct answer:** Isoniazid is a classic cause of **hepatocellular (hepatotoxic) injury**, not cholestatic jaundice. It causes an elevation in serum transaminases (ALT/AST) due to the formation of toxic metabolites (like acetylhydrazine) via the N-acetyltransferase pathway. In severe cases, it can lead to hepatic necrosis resembling viral hepatitis. **2. Analysis of Incorrect Options (Drugs causing Cholestasis):** * **Erythromycin estolate:** This is the most common salt of erythromycin associated with **acute cholestatic hepatitis**. It is often considered a hypersensitivity reaction and is a classic "textbook" cause of cholestasis. * **Oral Contraceptive Pills (OCPs):** Estrogens in OCPs can interfere with the transport of bile salts across the canalicular membrane, leading to **dose-dependent cholestasis** and occasionally "bland cholestasis" without significant inflammation. * **Chlorpromazine:** This antipsychotic is a well-known cause of **cholestatic jaundice** via a hypersensitivity-type reaction, typically occurring within the first few weeks of treatment. **NEET-PG High-Yield Pearls:** * **Hepatocellular Pattern:** INH, Rifampicin, Pyrazinamide, Paracetamol, Halothane, and Sodium Valproate. * **Cholestatic Pattern:** Anabolic steroids, Methyltestosterone, Chlorpromazine, Erythromycin estolate, and OCPs. * **Mixed Pattern:** Phenytoin, Carbamazepine. * **Note:** Among Anti-TB drugs, **Pyrazinamide** is the most hepatotoxic, while **Ethambutol** is the least (usually considered non-hepatotoxic).
Explanation: **Explanation:** The physiological effects of histamine are mediated through different receptors (H1, H2, H3, and H4). Understanding the localization of these receptors is key to distinguishing their functions. **Why Option C is correct:** **Gastric acid secretion** is primarily mediated by **H2 receptors** located on the parietal cells of the stomach. Stimulation of H2 receptors increases cAMP, leading to acid release. Therefore, H2 antagonists (like Ranitidine or Famotidine) are used to decrease gastric acid, not H1 antagonists. **Why the other options are incorrect:** * **A. Antipruritic:** H1 receptors are located on peripheral nerve endings. Their activation causes itching and pain. H1 antagonists block this, making them effective antipruritic agents. * **B. Sedation:** First-generation H1 antagonists (e.g., Diphenhydramine, Promethazine) are highly lipophilic and cross the blood-brain barrier. They inhibit central H1 receptors involved in wakefulness, leading to sedation. * **C. Antivertigo:** H1 receptors in the vestibular apparatus and the vomiting center play a role in equilibrium. Drugs like Meclizine and Cinnarizine are used to treat vertigo and motion sickness. **NEET-PG High-Yield Pearls:** * **First-generation H1 blockers:** Have significant anticholinergic, anti-alpha-adrenergic, and anti-serotonergic effects (e.g., Cyproheptadine is used as an appetite stimulant). * **Second-generation H1 blockers:** (e.g., Cetirizine, Loratadine) are non-sedating because they have poor CNS penetration and higher albumin binding. * **Terfenadine/Astemizole:** These older second-generation drugs were withdrawn due to the risk of **Torsades de Pointes** (QT prolongation) when co-administered with CYP3A4 inhibitors (like Erythromycin or Ketoconazole). Fexofenadine is the safe active metabolite of Terfenadine.
Explanation: **Explanation:** **Malathion** is an **Organophosphate (OP) compound**, which acts by irreversibly inhibiting the enzyme Acetylcholinesterase (AChE). This leads to an accumulation of Acetylcholine (ACh) at muscarinic and nicotinic receptors, causing a "cholinergic crisis." **Why Pralidoxime is correct:** Pralidoxime (2-PAM) is a **Cholinesterase Reactivator**. It works by cleaving the phosphate group from the anionic site of the inhibited AChE enzyme, thereby restoring its activity. It is specifically effective against the **nicotinic effects** (like muscle fasciculations and paralysis). It must be administered early, before "aging" of the enzyme-toxin bond occurs. **Why other options are incorrect:** * **Rivastigmine:** This is a carbamate-type reversible AChE inhibitor used in Alzheimer’s disease. Administering it would worsen the cholinergic crisis by further inhibiting the enzyme. * **Atropine:** While Atropine is a crucial part of the treatment for OP poisoning, it only antagonizes **muscarinic** effects (bradycardia, secretions). It does not reactivate the enzyme or treat nicotinic toxicity. *Note: In many clinical scenarios, both are used, but Pralidoxime is the specific antidote for the enzyme inhibition itself.* * **d-Tubocurarine:** This is a skeletal muscle relaxant (competitive nicotinic antagonist). It is contraindicated as it can exacerbate respiratory failure in the context of OP poisoning. **High-Yield Clinical Pearls for NEET-PG:** * **Atropinization:** The goal of treatment is to dry up secretions (monitored by clearing of lung crepitations). * **Aging:** Once the OP-enzyme complex "ages," oximes become ineffective. * **Differentiating Carbamate vs. OP poisoning:** Oximes (Pralidoxime) are generally **avoided in Carbaryl (carbamate) poisoning** because the enzyme-carbamate bond is reversible and oximes may worsen the toxicity.
Principles of Clinical Pharmacology
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Drug Toxicity and Overdose
Practice Questions
Antidotes and Their Applications
Practice Questions
Management of Drug Poisoning
Practice Questions
Drug-Induced Liver Injury
Practice Questions
Drug-Induced Kidney Injury
Practice Questions
Drug-Induced Blood Dyscrasias
Practice Questions
Drug-Induced QT Prolongation
Practice Questions
Pharmacovigilance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free